News Inspire your next round of molecule design through insightful analysis Feb 15, 2022 Posted by Cresset
News EdiGene Announces Publication by Company Scientific Founder in Nature Biotechnology of LEAPER™ 2.0, an Updated Version of the RNA Base Editing Technology using Engineered Circular ADAR-recruiting RNA Feb 11, 2022
News EdiGene and Neukio Enter Collaboration to Develop Next-Generation Immune Cell Therapies Feb 11, 2022
News EdiGene and Arbor Biotechnologies Announce Worldwide Non-exclusive License Agreement to Advance Ex Vivo Engineered Cell Therapy Programs Feb 11, 2022
News EdiGene Enters Research Collaboration to Develop Gene-editing Therapies for Inherited Retinal Degeneration with Peking Union Medical College Hospital Feb 11, 2022
News EdiGene Enters Strategic R&D Collaboration with Haihe Laboratory of Cell Ecosystem to Develop Hematopoietic Stem Cell Regenerative Therapies and Platform Technologies Feb 11, 2022
